- Trials with a EudraCT protocol (10,300)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
10,300 result(s) found.
Displaying page 1 of 515.
EudraCT Number: 2017-004506-18 | Sponsor Protocol Number: LYMRIT-37-07 | Start Date*: 2018-06-13 | |||||||||||
Sponsor Name:Nordic Nanovector ASA | |||||||||||||
Full Title: A phase 2 open-label study of Betalutin in combination with rituximab in patients with relapsed/refractory follicular lymphoma (Archer-1) | |||||||||||||
Medical condition: Follicular lymphoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003461-17 | Sponsor Protocol Number: 71272 | Start Date*: 2020-01-07 |
Sponsor Name:Amsterdam UMC, location VUmc | ||
Full Title: Pathophysiological relevance of IRON deficiency and related mitochondrial dysfunction in Heart Failure with Preserved Ejection Fraction (IRON-HFpEF) | ||
Medical condition: Heart failure with preserved ejection fraction | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-004148-53 | Sponsor Protocol Number: M18ICR | Start Date*: 2019-03-19 | |||||||||||
Sponsor Name:NKI-AVL | |||||||||||||
Full Title: ICRA (Improve Checkpoint-blockade Response in Advanced urothelial cancer), an adaptive clinical study to determine efficacy of combining weekly paclitaxel with tremelimumab +/- durvalumab (MEDI4736) | |||||||||||||
Medical condition: Metastatic urothelial carcinoma patients or patients with irresectable disease who were previously treated with chemotherapy - or are cisplatin-ineligible - and have progressed during or after trea... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003958-16 | Sponsor Protocol Number: NL63056.018.17 | Start Date*: 2018-08-10 | |||||||||||
Sponsor Name:Academic Medical Center, University of Amsterdam | |||||||||||||
Full Title: Effect of Reslizumab on small airways in asthma. RESSAPEA | |||||||||||||
Medical condition: 1. Patients with severe eosinophilic asthma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002564-10 | Sponsor Protocol Number: AP-CL-OTHER-PI-12868 | Start Date*: 2019-04-23 |
Sponsor Name:Universitair Medisch Centrum Groningen | ||
Full Title: Short-term safety, efficacy and mode of action of apremilast in mild to moderate cutaneous pemphigoid: a phase IIa open label single arm study. | ||
Medical condition: Pemphigoid | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-003476-12 | Sponsor Protocol Number: UMCU-VASC-CO-002 | Start Date*: 2019-09-12 |
Sponsor Name:University Medical Center Utrecht | ||
Full Title: A multicenter, randomized, double-blind, placebo-controlled, crossover trial to evaluate the effects of evolocumab added to standard lipid-lowering therapy on fasting and post fat load lipids in pa... | ||
Medical condition: Familial Dysbetalipoproteinemia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-003650-40 | Sponsor Protocol Number: DEPTHip2016 | Start Date*: 2015-12-01 | ||||||||||||||||
Sponsor Name:Amsterdam UMC, locatie AMC | ||||||||||||||||||
Full Title: Delirium in Elderly Patients with Trauma of the Hip | ||||||||||||||||||
Medical condition: hip fracture | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-004398-33 | Sponsor Protocol Number: M15DRU | Start Date*: 2016-04-20 |
Sponsor Name:Netherlands Cancer Institute | ||
Full Title: The Drug Rediscovery Protocol (DRUP trial) A Dutch National Study on behalf of the Center for Personalized Cancer Treatment (CPCT) to Facilitate Patient Access to Commercially Available, Targeted A... | ||
Medical condition: Advanced solid tumors (including glioblastoma multiforma), multiple myeloma or B cell non-Hodgkin lymphoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-002078-30 | Sponsor Protocol Number: NL70122.078.20 | Start Date*: 2020-06-19 |
Sponsor Name:Erasmus MC | ||
Full Title: Autoimmune epilepsy Modulated by IVIg – effects on Cortical Excitability, the AMICE study | ||
Medical condition: Auto-immune epilepsy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-010093-38 | Sponsor Protocol Number: HyRec | Start Date*: 2012-08-15 | ||||||||||||||||||||||||||
Sponsor Name:Dekan of the Medical Faculty of the University Erlangen-Nuremberg; Prof. Dr. Dr. h. c. Jürgen Schüttler | ||||||||||||||||||||||||||||
Full Title: Multi-institutional Phase I/II Study: Neoadjuvant chemoradiation with 5-FU (or capecitabine) and oxaliplatin combined with deep regional hyperthermia in locally advanced or recurrent rectal cancer | ||||||||||||||||||||||||||||
Medical condition: Locally advanced primary or locally recurrent rectal cancer | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DE (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000449-11 | Sponsor Protocol Number: EP250567 | Start Date*: 2012-03-01 | |||||||||||
Sponsor Name:Eero Pesonen | |||||||||||||
Full Title: Heparin dose (300 IU/kg vs. 600 IU/kg) in coroanry artery bypass grafting | |||||||||||||
Medical condition: Patients undergoing elective coronary artery bypass grafting | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000550-60 | Sponsor Protocol Number: V7/22032018 | Start Date*: 2014-01-17 | |||||||||||
Sponsor Name:Medizinische Universität Wien, Klinische Abteilung für Nephrologie und Dialyse, Universitätsklinik für Innere Medizin 3 | |||||||||||||
Full Title: Pulsed oral sirolimus in autosomal dominant polycystic kidney disease | |||||||||||||
Medical condition: Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder characterized by the development and uncontrolled proliferation of innumerable epithelial-lined cysts that stem from renal... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002226-23 | Sponsor Protocol Number: 2013-002226-23 | Start Date*: Information not available in EudraCT |
Sponsor Name:University of Bergen, Department of Global Public Health and Primary Care | ||
Full Title: Efficacy of Pain Treatment on Depression in Patients with Dementia. A Randomized Clinical Trial of Efficacy | ||
Medical condition: Depression Pain Dementia | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-005279-18 | Sponsor Protocol Number: RG_11-164 | Start Date*: 2012-02-08 | ||||||||||||||||
Sponsor Name:University of Birmingham | ||||||||||||||||||
Full Title: A RandoMised study of best Available therapy versus JAK Inhibition in patients with high risk Polycythaemia Vera or Essential Thrombocythaemia who are resistant or intolerant to HydroxyCarbamide. | ||||||||||||||||||
Medical condition: Polycythaemia vera Essential Thrombocythaemia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-015316-17 | Sponsor Protocol Number: 01AneInt2009 | Start Date*: 2017-11-17 | |||||||||||
Sponsor Name:Oslo Universitetssykehus - Rikshospitalet | |||||||||||||
Full Title: Perioperativ administrasjon av pregabalin ved laparoskopisk living donor nefrektomi (L-LDN) - et adjuvans til peroral analgetisk behandling - en randomisert kontrollert studie | |||||||||||||
Medical condition: Hensikten med studien er å undersøke om perioperativ administrasjon av pregabalin vil redusere postoperativ smerte og forbruket av intravenøse opioider postoperativt sammenliknet med dagens standar... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002255-42 | Sponsor Protocol Number: MK-3222-010 | Start Date*: 2013-01-10 | |||||||||||
Sponsor Name:Sun Pharma Global FZE | |||||||||||||
Full Title: A 64-Week, Phase 3, Randomized, Placebo-Controlled, Parallel Design Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous Tildrakizumab (SCH 900222/MK-3222), Followed by an Optiona... | |||||||||||||
Medical condition: Moderate-to-Severe Chronic Plaque Psoriasis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-004974-82 | Sponsor Protocol Number: 2013.837 | Start Date*: 2014-04-04 | ||||||||||||||||
Sponsor Name:Hospices Civils de Lyon | ||||||||||||||||||
Full Title: PETALS study : PEgylated interferon-alpha2a and TAsigna® for first Line therapy of Philadelphia chromosome-positive chronic phase CML patientS | ||||||||||||||||||
Medical condition: Chronic phase chronic myeloid leukaemia with Philadelphia chromosome positive or BCR-ABL positive | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000919-22 | Sponsor Protocol Number: OMB114578 | Start Date*: 2011-09-14 | |||||||||||
Sponsor Name:University of Liverpool [...] | |||||||||||||
Full Title: RIAltO: A Randomised Investigation of Alternative Ofatumumab-containing regimens in less fit patients with CLL | |||||||||||||
Medical condition: Chronic Lymphocytic Leukaemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-004787-62 | Sponsor Protocol Number: DUS | Start Date*: 2014-11-26 | |||||||||||
Sponsor Name:SOD Anestesia e Terapia Intensiva, DAI Oncologia, AOU Careggi, Firenze | |||||||||||||
Full Title: Evaluation of muscle function recovery after deep neuromuscular blockade by acceleromyography of the adductor pollicis or diaphragmatic echography: comparison between sugammadex and neostigmine | |||||||||||||
Medical condition: Muscle function recovery post neuromuscoular blockade | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-005095-28 | Sponsor Protocol Number: IRST186.02 | Start Date*: 2015-04-16 | |||||||||||
Sponsor Name:ISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI (IRST) S.R.L. IRCCS | |||||||||||||
Full Title: Olaparib as salvage treatment for cisplatin-resistant germ cell tumor. | |||||||||||||
Medical condition: cisplatin-resistant germ cell tumor | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
